https://www.bqprime.com/markets/cipla-shares-slips-7-after-us-fda-issues-warning-letter-for-pithampur-facility
0
0
33 words
0
Comments
There were violations of current good manufacturing practices regulations for finished pharmaceuticals, the letter said.
You are the first to view
Create an account or login to join the discussion